Condition
Gastric Neoplasia
Total Trials
4
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown2
Not Yet Recruiting1
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07395570Not ApplicableActive Not RecruitingPrimary
Efficacy of CADe System in Detecting Gastric Neoplasia
NCT06853509Not Yet RecruitingPrimary
Predicting Gastric Neoplasia in Patients with High-risk Endoscopic Features
NCT02863965UnknownPrimary
High Definition Endoscopy and Optic Enhancement Endoscopy in Gastric Neoplasia: A Prospective Study
NCT02063932Unknown
Association Between Confocal Laser Endomicroscopic (CLE) Features and Gastric Mucosal Microbiome
Showing all 4 trials